Human Microbiome Market Size, Share, And Trends Analysis Report By Product Type (Probiotics, Prebiotics, Symbiotics), By Application (Therapeutics, Diagnostics), By Diseases (Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders) Based On Region, And Segment Forecasts, 2021 - 2028

  • Report ID: BMRC 483 | Number of pages: 197 | Published Date: Jan 2022

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Human Microbiome Market Size, Share, And Trends Analysis Report By Product Type (Probiotics, Prebiotics, Symbiotics), By Application (Therapeutics, Diagnostics), By Diseases (Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders) Based On Region, And Segment Forecasts, 2021 - 2028 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Human Microbiome Market is valued at USD 551.85 Million in 2021 and is expected to reach USD 2107.81 Million by 2028 with a CAGR of 21.1% over the forecast period.

The Human Microbiome Market report is segmented on the basis of product type, diseases, application, and region & country level. Based on product type, the global human microbiome market is classified as probiotics, prebiotics, symbiotics, and others. Based upon diseases, the global human microbiome market is classified into obesity, diabetes, autoimmune disorder, cancer, gastrointestinal disorders, central nervous system disorders, and others. Based upon application, the global human microbiome market is classified as therapeutics and diagnostics.

Market Analysis of Human Microbiome:-

The human microbiome is the aggregate of all microbiota that resides on or within any of a number of human tissues and biofluids, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary, and gastrointestinal tracts. It includes; bacteria, archaea, fungi, protists, and viruses. As per recent estimates, a human body harbors microorganisms having a ratio of 3:1 compared to the number of human cells present. The relationship of most microbes with the human body ranges from being commensal and mutualistic to neutral and harmful.

Human microbiome-based therapies are available in the form of foods, prebiotics, diagnostic devices, probiotics, medical foods, drugs, and supplements. Technological advancements in metagenomics and next-generation sequencing have made microbiome-based testing easier and cheaper, and have led to the rapid analysis of the genomic content of microorganisms from human samples. This has boosted the development process for microbiome-based diagnostics.

The regions covered in this human microbiome market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, a market of the Human Microbiome is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Human Microbiome Companies

Global human microbiome market report covers prominent players like Avidbiotics Inc., Avidbiotics Corp., 4D Pharma, Series Therapeutics, Second Genome, Enterome, Microbiome Therapeutics, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DuPont, BiomX Ltd., and others.

Human Microbiome

Human Microbiome Market Key Segmentation:-

By Product Type:

  • Probiotics
  • Prebiotics
  • Symbiotics
  • Other Products

By Application:

  • Therapeutics
  • Diagnostics

 By Diseases:

  • Obesity
  • Diabetes
  • Autoimmune Disorder
  • Cancer
  • Gastrointestinal Disorders
  • Central Nervous System Disorders
  • Other Diseases

Market Dynamics–

The increasing incidences of lifestyle diseases are expected to drive the growth of the global human microbiome market. According to the World Health Organization, in 2016, 13% of the world population (adults) was obese. As per the New Era of Treatment of Obesity and Metabolic Disorders, published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity. However, stringent government regulations related to the approval of human microbiome-based therapies are creating a major weakness to the growth of the market. Moreover, growing investments by governments in the development of human microbiome-based therapies are creating abundant growth opportunities for the global market for the human microbiome.

North America is Expected to Dominate the Global Market

North America is expected to dominate the global human microbiome market and held a major market share due to the growing funding and research and development activities by companies and research institutes in this region. The presence of a large number of players who are adopting various initiatives such as investment in research and development for the development of the new therapeutic area for the microbiome to prevent health issues such as irritable bowel syndrome, immune diseases, etc. is further contributing to the market in this region.

The Asia-Pacific market is anticipated to be the fastest-growing region for the human microbiome market attributed to the rising government funding in personalized medicine and the emergence of numerous initiatives to develop the human microbiome in countries such as China, Japan. These initiatives aim to optimize the methods for the assessment of the effect of the gut microbiome on human health through the standardization of protocols and procedures.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2028
Market Size in 2020: USD 551.85 Million 
Base year considered 2020
Forecast Period CAGR %:

 21.1% 

Market Size Expected in 2028: USD 2107.81 Million 
Tables, Charts & Figures: 175
Pages 200
Human Microbiome Companies Avidbiotics Inc., Avidbiotics Corp., 4D Pharma, Series Therapeutics, Second Genome, Enterome, Microbiome Therapeutics, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DuPont, BiomX Ltd., and others
Segments Covered By Product Type, By Application, By Diseases
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Human Microbiome Market Report–

  • Global Human Microbiome Market report covers in-depth historical and forecast analysis.
  • Global Human Microbiome Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Human Microbiome Market report helps to identify opportunities in the marketplace.
  • Global Human Microbiome Market report covers an extensive analysis of emerging trends and competitive landscape.

By Regional & Country Analysis:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA


Frequently Asked Questions (FAQ) :
The Global Human Microbiome Market size is expected to garner $2107.81 Million by 2028, registering a CAGR of 21.1% during the forecast period
The increasing incidences of lifestyle diseases are expected to drive the growth of the global human microbiome market.
Avidbiotics Inc., Avidbiotics Corp., 4D Pharma, Series Therapeutics, Second Genome, Enterome, Microbiome Therapeutics, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DuPont, BiomX Ltd., and others
By Product Type, By Application, By Diseases
North America is Expected to Dominate the Global Market



Interested in this report?

Human Microbiome Market Size, Share, Trends, Growth, And Industry Analysis By 2028

report cover

Human Microbiome Market Size, Share, And Trends Analysis Report By Product Type (Probiotics, Prebiotics, Symbiotics), By Application (Therapeutics, Diagnostics), By Diseases (Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders) Based On Region, And Segment Forecasts, 2021 - 2028

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?